[{"Assets_0_Q2_USD":148923066.0,"CommonStockSharesOutstanding_0_Q2_shares":91474395.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-31598274.0,"NetIncomeLoss_1_Q2_USD":-6639125.0,"NetIncomeLoss_2_Q2_USD":-38989953.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":91241660.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":90890792.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":91153776.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":90804722.0,"StockholdersEquity_0_Q2_USD":111395551.0,"EarningsPerShareBasic_1_Q2_USD":-0.07,"EarningsPerShareBasic_2_Q2_USD":-0.43,"EarningsPerShareDiluted_1_Q2_USD":-0.08,"EarningsPerShareDiluted_2_Q2_USD":-0.43,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":24448761.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":25978405.0,"Ticker":"INO","CIK":"1055726","name":"INOVIO PHARMACEUTICALS, INC.","OfficialName":"Inovio Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"674206680.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20180807"}]